Pulmonary Fibrosis Research Enhancement Act Re-Introduced in U.S. Congress
Pulmonary Fibrosis Research Enhancement Act Re-Introduced in U.S. Congress
Contact: Teresa Barnes, Coalition for Pulmonary Fibrosis, +1-303-521-4080, tbarnes@coalitionforpf.org
Read more on PR Newswire via Yahoo! News
Categories: Breast Cancer Information Tags: Congress, Enhancement, Fibrosis, Pulmonary, ReIntroduced, research, U.S.
Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congress
Oncologists discuss about NCCN updated guidelines at 4th Annual Asia Scientific Congress
More than 1,800 Chinese oncology professionals attended the NCCN 4th Annual Asia Scientific Congress in Shanghai, China, on April 9, 2011, which featured expert faculty from NCCN Member Institutions and thought leaders in cancer care from major Chinese cancer centers.
Read more on News-Medical-Net
Categories: Breast Cancer Awareness Tags: About, annual, Asia, Congress, Discuss, Guidelines, Nccn, Oncologists, Scientific, UPDATED
Allos Therapeutics Announces FOLOTYN® Data Presentation at the 35th ESMO Congress
Allos Therapeutics Announces FOLOTYN® Data Presentation at the 35th ESMO Congress
WESTMINSTER, Colo.–(BUSINESS WIRE)–Allos Therapeutics, Inc. (Nasdaq: ALTH) today announced that results from the Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) will be presented at the 35th European Society of Medical Oncology (ESMO) Congress — Milan, Italy from October 8-12, 2010 …
Read more on Business Wire
Categories: High Risk Breast Cancer Tags: 35th, Allos, Announces, Congress, Data, ESMO, FOLOTYN®, Presentation, Therapeutics'
Ph II data of perifosine + capecitabine in metastatic CRC to be presented at gastrointestinal cancer congress
Ph II data of perifosine + capecitabine in metastatic CRC to be presented at gastrointestinal cancer congress
Keryx Biopharmaceuticals, Inc. today announced that abstract O-0017, entitled “Subset Analysis of 5-FU Refractory Patients from a Randomized Ph II Study of Perifosine + Capecitabine (P-CAP) vs. Placebo + Capecitabine (CAP) in Patients with 2nd or 3rd Line Metastatic CRC” has been selected for oral presentation at the upcoming 12th World Congress on Gastrointestinal Cancer, to be held in …
Read more on News-Medical-Net
Categories: Breast Cancer Chemotherapy Tags: cancer, capecitabine, Congress, Data, gastrointestinal, Metastatic, perifosine, presented
IOF WCO-ECCEO10 osteoporosis congress opens in Florence, Italy
IOF WCO-ECCEO10 osteoporosis congress opens in Florence, Italy
A record number of researchers and clinicians from some 100 countries gathered today in Florence, Italy to share new information about osteoporosis, a serious chronic disease which leads to weakened bones and fractures in as many as one in three women and one in five men over the age of fifty.
Read more on News-Medical-Net
Categories: Breast Cancer Treatment Options Tags: Congress, Florence, Italy, opens, Osteoporosis, WCOECCEO10